MTS


MTS is a digital health firm specializing in AI-driven cancer diagnostic and prognostic solutions. The platform provides artificial intelligence to analyze histopathology images, providing accurate assessments of pathological markers and prognostic predictions for various cancers. MTS offers AI solutions to predict lymphatic metastasis rates, anticipated responses to anticancer treatments, and personalized treatment planning.

Industries

artificial-intelligence
health-care
health-diagnostics

Nr. of Employees

small (1-50)

MTS

Seoul, Seoul-t'ukpyolsi, South Korea, Asia


Patents

Combination piezoelectric actuator and sensor

US-12395100-B2

View Details

Testing machine with actuator and column brace

US-11852613-B2

View Details

Electric actuator

US-11846609-B2

View Details

Support jig with improved support grips

US-11808738-B2

View Details

Extensometer structure

US-10852118-B2

View Details

Testing machine with graphical user interface with situational awareness

US-10712719-B2

View Details
View All Patents

Products

AiAlpa-Platform

An AI platform designed for medical diagnosis and prediction related to cancer.

AI Doc-Mobile

A mobile application that provides AI-powered medical diagnostic support for cancer detection.

Colposcopy Board

A tool for managing and analyzing colposcopy data to assist in cervical cancer diagnosis.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.